» Articles » PMID: 23237552

On the Origin of Cancer Metastasis

Overview
Journal Crit Rev Oncog
Publisher Begell House
Specialty Oncology
Date 2012 Dec 15
PMID 23237552
Citations 514
Authors
Affiliations
Soon will be listed here.
Abstract

Metastasis involves the spread of cancer cells from the primary tumor to surrounding tissues and to distant organs and is the primary cause of cancer morbidity and mortality. In order to complete the metastatic cascade, cancer cells must detach from the primary tumor, intravasate into the circulatory and lymphatic systems, evade immune attack, extravasate at distant capillary beds, and invade and proliferate in distant organs. Currently, several hypotheses have been advanced to explain the origin of cancer metastasis. These involve an epithelial mesenchymal transition, an accumulation of mutations in stem cells, a macrophage facilitation process, and a macrophage origin involving either transformation or fusion hybridization with neoplastic cells. Many of the properties of metastatic cancer cells are also seen in normal macrophages. A macrophage origin of metastasis can also explain the long-standing "seed and soil" hypothesis and the absence of metastasis in plant cancers. The view of metastasis as a macrophage metabolic disease can provide novel insight for therapeutic management.

Citing Articles

Integrating model systems and genomic insights to decipher mechanisms of cancer metastasis.

Leung M, Swanton C, McGranahan N Nat Rev Genet. 2025; .

PMID: 40065153 DOI: 10.1038/s41576-025-00825-2.


Integrin and Its Associated Proteins as a Mediator for Mechano-Signal Transduction.

Katoh K Biomolecules. 2025; 15(2).

PMID: 40001469 PMC: 11853369. DOI: 10.3390/biom15020166.


Cell fusion as a driver of metastasis: re-evaluating an old hypothesis in the age of cancer heterogeneity.

Lopez-Collazo E, Hurtado-Navarro L Front Immunol. 2025; 16:1524781.

PMID: 39967663 PMC: 11832717. DOI: 10.3389/fimmu.2025.1524781.


Integrins as Key Mediators of Metastasis.

Caceres-Calle D, Torre-Cea I, Marcos-Zazo L, Carrera-Aguado I, Guerra-Paes E, Berlana-Galan P Int J Mol Sci. 2025; 26(3).

PMID: 39940673 PMC: 11816423. DOI: 10.3390/ijms26030904.


Influences of aqua-(2-formylbenzoato) triphenyltin(IV) on regression of hypoxic solid tumor through mitochondrial mediated pathway by inhibiting Hif-1 alpha.

Singh V, Singh R, Goswami P, Manna P, Basu Baul T, Mandal A Sci Rep. 2025; 15(1):5302.

PMID: 39939702 PMC: 11821849. DOI: 10.1038/s41598-025-89761-z.


References
1.
Campbell P, Yachida S, Mudie L, Stephens P, Pleasance E, Stebbings L . The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature. 2010; 467(7319):1109-13. PMC: 3137369. DOI: 10.1038/nature09460. View

2.
Chen E, Grote E, Mohler W, Vignery A . Cell-cell fusion. FEBS Lett. 2007; 581(11):2181-93. DOI: 10.1016/j.febslet.2007.03.033. View

3.
Matarrese P, Ciarlo L, Tinari A, Piacentini M, Malorni W . Xeno-cannibalism as an exacerbation of self-cannibalism: a possible fruitful survival strategy for cancer cells. Curr Pharm Des. 2008; 14(3):245-52. DOI: 10.2174/138161208783413239. View

4.
Ward D, Roberts K, Brookes M, Joy H, Martin A, Ismail T . Increased hepcidin expression in colorectal carcinogenesis. World J Gastroenterol. 2008; 14(9):1339-45. PMC: 2693679. DOI: 10.3748/wjg.14.1339. View

5.
Strojnik T, Kavalar R, Zajc I, Diamandis E, Oikonomopoulou K, Lah T . Prognostic impact of CD68 and kallikrein 6 in human glioma. Anticancer Res. 2009; 29(8):3269-79. View